- Report
- November 2024
- 130 Pages
Global
From €4167EUR$4,650USD£3,575GBP
- Report
- October 2023
- 131 Pages
Global
From €4167EUR$4,650USD£3,575GBP
- Report
- June 2025
- 400 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- June 2025
- 250 Pages
India
From €2500EUR$2,789USD£2,144GBP
- Report
- March 2023
- 141 Pages
Global
From €3225EUR$3,599USD£2,767GBP
- Report
- July 2021
- 255 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- July 2024
- 100 Pages
Global
From €3361EUR$3,750USD£2,883GBP
- Report
- July 2024
- 120 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- July 2024
- 120 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- July 2024
- 120 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- July 2024
- 120 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- July 2024
- 120 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- July 2024
- 120 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- July 2024
- 170 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- February 2024
- 112 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- April 2023
- 116 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- February 2024
- 150 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- July 2025
- 350 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- May 2025
- 216 Pages
Global
From €2241EUR$2,500USD£1,922GBP
- Report
- December 2024
- 196 Pages
Global
From €2241EUR$2,500USD£1,922GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more